Patent Litigation over COVID-19 vaccine – IPR has been filed, according to the company.

Last summer, I wrote about Modela’s patent lawsuit against Pfizer and Biontec over the COVID-19 vaccine and the subsequent filing of a response by the two companies being sued,

Patent Litigation over COVID-19 vaccine

Patent lawsuit over COVID-19 vaccine Subsequently

Two more companies have filed an IPR (Inter partes review) with the USPTO regarding the Modeler patent.

https://www.biospace.com/article/pfizer-biontech-challenge-moderna-s-covid-19-patents-with-uspto/

When I briefly looked through Modela’s patents last year, I got the impression that the claim scope was quite broad, so it was to be expected that the two companies would file an IPR.

I checked with P-TACTS and it appears that IPRs have been filed for the following patents.

10,702,600 (the “‘600 patent”) : Betacolonavirus mRNA vaccine

10,933,127 (the “‘127 patent”) : Betacolonavirus mRNA vaccine

We will continue to monitor the outcome of these IPRs in the future, as they seem to be quite voluminous documents.

Photo: Saint-Sulpice Church in Paris, which I visited this summer.